课题基金 / 基金详情

Comprehensive Genomics

Comprehensive Genomics
综合基因组学
批准号:
10357805
负责人:
Shridar Ganesan
金额:
$3.79万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-03-01 至 2023-02-28

项目摘要

项目成果

Shridar Ganesan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
COMPREHENSIVE GENOMICS SHARED RESOURCE PROJECT SUMMARY/ABSTRACT Comprehensive Genomics is integral to understanding the molecular pathophysiology of cancer and the discovery of improved diagnostics and treatments. The Comprehensive Genomics shared resource (Genomics) of Rutgers Cancer Institute of New Jersey (CINJ) is an Institutionally managed shared resource whose purpose is to provide centralized, high quality, cost-effective cutting edge genomic analyses of cells and tissues. This shared resource has been greatly expanded over the last grant period and now resides within the Rutgers University Cell and DNA Repository (RUCDR-Infinite Biologics) and includes a large suite of next-generation sequencing technologies. This reorganization allowed CINJ to address the suggestion to develop next- generation sequencing capabilities by leveraging the significant resources and instrumentation available at RUCDR to serve the needs of Cancer Center investigators. The two highly trained and experienced CINJ staff members remain with the shared resource and now work within RUCDR, dedicated to serving the needs of Cancer Center members. Both staff members report to the Co-Directors, provide local consultation services, and arrange for seamless sample transfer. RUCDR is home to state-of-the-art biosample-processing instrumentation, robotic workflows (including a fully automated robotics facility for sample handling from nucleic acid extraction to sequencing), integrated quality control, and a suite of sequencing platforms. Sequencing data is transmitted back to investigators either on flash drives or electronically, usually in coordination with the Biomedical Informatics shared resource.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 3: Chromatin modifiers of BRCA-related DNA repair Pathways
Project 3: Chromatin modifiers of BRCA-related DNA repair Pathways
Impact of mutation burden on cancer growth and the immune landscape
Evolution and clinical impact of clonal hematopoiesis of indeterminate potential in breast tumor microenvironment
海外基金